Biostatistics and Databases Program

The Biostatistics and Databases Program has a collaborative biostatistical research role across many of the Centre’s programs and activities. This includes ensuring the statistical design and analysis of clinical trials and epidemiological studies are to appropriate international standards. The Program also develops traditional CRF and web-based databases, for research studies and national surveillance activities.

In addition to collaborative activities with other programs, the Program has independent research activities in a number of areas. First, the Program leads a number of large, observational cohort studies. These include adult HIV cohorts in Australia and Asia, paediatric HIV cohorts in Asia, and an adult HCV cohort in Australia. These studies aim to assess treatment and outcomes in HIV and HCV disease. Second, the Program has an active mathematical modeling group. This group is largely focused on transmission, and interventions aimed at preventing transmission, of certain sexually transmissible infections, including HPV, gonorrhoea and Chlamydia. Third, the Program has an active interest in linkage studies, including linkage of HIV, HBV, HCV and cohort studies to hospitalization, cancer and death registries. These linkage studies describe longer term outcomes and epidemiological patterns.

	Matthew Law MA MSc, PhD Head and Professor Professor Matthew Law is Head of the Biostatistics and Databases Program. He is a biostatistician with a background in mathematics and statistics. His research interests include randomized trials, observational cohorts and linkage studies in HIV, HCV and STIs. mlaw@nchecr.unsw.edu.au
	John Murray BSc(Hons), MSc, PhD Associate Professor John Murray is a mathematician whose primary appointment is at the School of Mathematics and Statistics, University of New South Wales. He works in the areas of dynamical modelling of infectious diseases in vivo, as well as their spread through the community. jmurray@nchecr.unsw.edu.au
	Janaki Amin BSc(Hons), MPH(Hons), PhD Senior Lecturer Janaki’s training and research is based in the fields of epidemiology and biostatistics. Her primary activities and interests include design and analysis of clinical trials and data linkage studies, analysis of cohort studies and training and student supervision. jamin@nchecr.unsw.edu.au
	David Regan BA, BSc (Hons), PhD Senior Lecturer David Regan is a mathematical modeller. His research activity focuses on the development of mathematical models of STI transmission for the evaluation of public health strategies for the control and prevention of STIs. His interests include estimating the impact of human Papillomavirus vaccination in Australia, and the control of bacterial STIs (Chlamydia, syphilis, and gonorrhoea) and trichomoniasis in remote indigenous communities. dregan@nchecr.unsw.edu.au
	Handan Wand MA, MSc, PhD Senior Lecturer Handan Wand is a biostatistician and her research interests include HIV, HCV, STIs and randomized clinical trials. hwand@nchecr.unsw.edu.au
	Jialun Zhou BMed, MPH, PhD Senior Lecturer Jialun Zhou is study coordinator of The TREAT Asia HIV Observational Database (TAHOD), as part of the Asia-Pacific components of the NIH global HIV research program, the International Epidemiological Database to Evaluate AIDS (IeDEA collaboration). He is also project statistician of the SECOND-LINE clinical trial. jzhou@nchecr.unsw.edu.au
	Kathy Petoumenos BSc, MA, MPH(Hons), PhD Senior Lecturer Kathy Petoumenos has interest and experience in observational cohort studies and clinical trials in HIV, Hepatitis C and sexually transmitted infections (STIs). She is currently the study leader for the Australian HIV Observational Database and lead statistician on both HIV and Hepatitis C clinical trials coordinated at NCHECR. kpetoumenos@nchecr.unsw.edu.au
	Azar Kariminia BSc, MSc, PhD Lecturer Azar Kariminia is study coordinator of the Therapeutic Research, Education and AIDS Training (TREAT) Asia Pediatric human immunodeficiency virus (HIV) Observational Database (TApHOD). This project is supported by grants from the Austrian AIDS Life Association and the US National Institutes of Health. akariminia@nchecr.unsw.edu.au
	Ben Hui BE(computer engineering), PhD Associate Lecturer Ben Hui is a mathematical modeller. His work involves the development of mathematical models for assessing the impact of interventions to reduce sexually transmitted infections (STIs). This work is currently focused on STI prevention in remote indigenous communities in Australia with limited access to health services. bhui@nchecr.unsw.edu.au
	Igor Korostil MSc Research Associate Igor Korostil works on the development of mathematical models of STI with a particular focus on simulation of HPV vaccination strategies. ikorostil@nchecr.unsw.edu.au
	Paul Fahey BSc, MMedStat Statistician Paul has 25 years experience as a biostatistician in health-related research areas. He works mainly with Janaki Amin. pfahey@nchecr.unsw.edu.au
	Heather Gidding MAppEpid, GradDip BiostatsEpid, BAppSci Statistician Heather is an infectious diseases epidemiologist. Her current research relates to hepatitis C associated morbidity and treatment. She is the project co-ordinator for the Australian Chronic Hepatitis C Observational Study (ACHOS), a multi-clinic study of treatment uptake and outcomes as well as disease progression. Heather recently completed a data linkage study examining hospitalisation rates in people with hepatitis C. hgidding@nchecr.unsw.edu.au
	Awachana Jiamsakul (Am) BSc, MStat Statistician Am joined NCHECR at the end of 2009. She is currently working on the TASER project: TREAT Asia Studies to Evaluate Resistance among the Asian population. ajiamsakul@nchecr.unsw.edu.au
	Hamish McManus BEcon, BActS, MBIOS Statistician Hamish joined NCHECR at the end of 2009 as a statistician working on the Australian HIV Observational Database. hmcmanus@nchecr.unsw.edu.au
	Rebecca Oyomopito BSc, Grad Dip MedStat Statistician Rebecca is a PhD fellow and Statistician investigating HIV drug resistance in Asia. She has worked at Harvard School of Public Health on paediatric HIV/AIDS clinical trials in the US and the Organisation for Economic Co-operation and Development (OECD)in Paris, France. royomopito@nchecr.unsw.edu.au
	Stephen Wright BMath, MAppStat Statistician Stephen joined NCHECR in 2010 as a statistician primarily working on the Australian HIV Observational Database (AHOD). swright@nchecr.unsw.edu.au
	Rossitza Chevkenova BSc, MSc Computer Systems Officer Develops and designs client-server and web-based (Phase Forward) ORACLE – based applications for clinical trials data entry. rchevkenova@nchecr.unsw.edu.au
	Absar Noorul BTech (IIT,Bombay), GradDip(InfSc), MComp(SWWEngg) Computer Systems Officer Joined NCHECR in 2001. Design and develop the applications in Oracle client server architecture and for Web-based applications, Inform Software a Phase Forward solution is used. nabsar@nchecr.unsw.edu.au
	Courtney Bendall DipBus Program Coordinator Courtney joined the Biostatistics Program in 2008. She is the Program Coordinator as well as handles all administrative responsibilities of the Australian HIV Observational Database (AHOD). cbendall@nchecr.unsw.edu.au
	Supreet Mehik BHMS Administrative Assistant smehik@nchecr.unsw.edu.au
	Amit Achhra MBBS, MPH PhD Student Amit is a medical graduate with a keen interest in clinical epidemiology of HIV. Currently he is investigating predictors of serious outcomes in various HIV cohorts. aachhra@nchecr.unsw.edu.au
	Edward Waters PhD Student Ned is undertaking a PhD modelling the ecology of human papillomavirus infection and its implications for disease surveillance. His diverse research interests also include the social and mathematical aspects of spatial organisation and in statistical decision theory and epistemology. ewaters@nchecr.unsw.edu.au
	Kylie Mallitt BSc(Hons) PhD Student Kylie Mallitt is working on geospatial transmission models for HIV treatment pathways in Australian and South African populations, and forecasting outcomes in the context of different interventions. kmallitt@nchecr.unsw.edu.au
	Tarana Lucky MBBS, MPH, MHM PhD Student Tarana joined NCHECR in July, 2010. Her thesis encompasses the use of various quantitative techniques to improve monitoring and evaluation of HIV epidemics in Australia. Currently she is working on merging the national HIV and AIDS databases to establish a single national HIV registry and expecting to commence a project on national ‘Blood Donor Surveillance in Australia’ in collaboration with Australian Red Cross Blood Service (ARCBS) very soon. tlucky@nchecr.unsw.edu.au

Achhra AC; Amin J; Law MG; Emery S; Gerstoft J; Gordin F M; Vjecha MJ; Neaton JD; Cooper DA; for INSIGHT ESPRIT & SILCAAT study groups. Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS. 2010;24(12):1877-1886.

Achhra A, Zhou J, Dabis F, Pujari S, Thiebaut, Law MG, Bonnet F. Difference in absolute CD4+ count according to CD4 percentage between Asian and Caucasian HIV-infected patients. Journal of AIDS & Clinical Research 2010;1:101.doi:10.4172/2155-6113.1000101.

Allison WE, Kiromat M, Vince J, Wand H, Cunningham P, Graham SM, Kaldor J. Development of a clinical algorithm to prioritise HIV testing of hospitalised paediatric patients in a low resource moderate prevalence setting. Arch Dis Child. 2010 Nov 2. DOI: adc.2009.179143[pii] 10.1136/adc.2009.179143

Amin J, De Lazzari E, Emery S, Martin A, Martinez E, Carr A, Gatell J, Cooper DA. Simplification with Fixed-Dose Tenofovir-Emtricitabine or Abacavir-Lamivudine in Treatment Experienced, Virologically Suppressed Adults with Hiv Infection: Combined Analysis of Two Randomised, Non-Inferiority Trials Bicombo and Steal. J AIDS Clinic Res 2010. 1:103. doi:10.4172/2155-6113.1000103

Amin J, Martin A, Bloch M, Carr A. Reply to Landman and Soonawala. Clinical Infectious Diseases.2010;50(8):1200-1.

Ammaranond P, van Bockel DJ, Petoumenos K, McMurchie M, Finlayson R, Middleton MG, Davenport MO, Venturi V, Suzuki K, Gelgor L, Kaldor JM, Cooper DA, Kelleher AD. HIV immune escape at an Immuno-dominant Epitope in HLA-B*27 Positive Individuals Predicts Viral Load Outcome. The Journal of Immunology 2010 (Accepted).

Applegate T, Birkett D, McIntyre G, Jaramillo A, Symonds G, Murray JM, The development of HIV-1 resistance to multiple shRNA gene therapy differs to antiretroviral therapy. Retrovirology 2010; 7(83): 1-14.

Arnott A, Jardine D, Wilson K, Gorry PR, Merlin K, Grey P, Law MG, Dax EM, Kelleher AD, Smith DE, McPhee DA and the Pulse Study Team. High viral fitness during acute HIV-1 infection. PLoS One 2010;5(9):e12631.

Calmy A, Bloch M, Wand H, Delhumeau C, Finlayson R, Rafferty M, Norris R, Hirschel B, Cooper DA, Carr A for the URISTAT study group. No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial. HIV Med 2010;11:493-501.

Carey D, Amin J, Boyd M, Petoumenos K, Emery S. Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010 Sep;65(9):1878-88.

Corderoy DV, Hesse K, Amin J, Cooper DA. Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients. Antivir Ther 2010;15;1035-1038.

Couldwell DL, Gidding HF, Freedman EV, McKechnie ML, Biggs, K, Sintchenko V, Gilbert GL. Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. Int J STD & AIDS 2010; 21: 337–341.

Cysique L, Murray JM, Dunbar M, Jeyakumar V, Brew B. A screening algorithm for HIV associated neurocognitive disorders. HIV Medicine 2010. 11(10):642-649.

The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group (Law MG member of writing committee). Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS 2010;24:1537-1548.

Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infectious Disease. 2010 [Epub a head of print].

Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM for the Australian Trial In Acute Hepatitis C Study Group. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 2010;138:123-135.

Dunbar M, Murray JM, Cysique L, Brew B, Jeyakumar V. Simultaneous Classification and Feature Selection via Convex Quadratic Programming with Application to HIV-Associated Neurocognitive Disorder Assessment. European Journal of Operational Research 2010;206(2):470-478.

Falster K, Wand H, Donovan B, Anderson J, Nolan D, Watson K, Watson J, Law MG on behalf of the Australian HIV Observational Database. Hospitalizations in a cohort of HIV patients in Australia, 1999-2007. AIDS 2010;24:1329-1339.

French MA, Tanaskovic S, Law MG, Lim A, Fernandez S, Ward LD, Kelleher AD, Emery S. Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a ‘high affinity’ Fc?RIIa genotype. AIDS 2010;24(13):1983-90.

Friss-Moller N, Thiebault R, Reiss P, Weber R, D’Arminio Monforte S, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law M on behalf of the D:A:D Study Group. Predicting the risk of cardiovascular disease in HIV-infected patients. European Journal of Cardiovascular Prevention and Rehabilitation 2010;17(5):491-501.

Gao Z, Gidding HF, Wood JG, Macintyre CR. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect. 2010 Apr;138(4):457-68. Epub 2009 Sep 28

Gidding HF, Amin J, Dore GJ, Law MG. Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C. Epidemiol Infect 2010 (Accepted).

Gidding HF, Amin J, Dore GJ, Ward K, Law MG. Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia. Journal of Hepatology 2010;53:43-49.

Gidding HF, Dore GJ, Amin J, Law MG. Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study. BMC Public Health (accepted).

Grebely J, Matthews GV, Hellard M, Shaw D, van Beek I, Petoumenos K, Alavi M, Yeung B, Haber P, Lloyd AR, Kaldor JM, and Dore JD for the ATAHC Study Group. Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of Hepatology. 2010 Nov 23. (Epub ahead of print). PMID: 21145855.

Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, Applegate T, Yeung B, Marks P, Rawlinson W, Lloyd AR, Booth D, Kaldor JM, George J, Dore GJ; ATAHC Study Group. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology 2010 Oct; 52(4):1216-24.

Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M, for the ATAHC Study Group. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug Alcohol Depend 2010;107:244-249.

Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PCK, Ngorima N, Kantipong P, Osibogun A, Lee CKC, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YMA, Schuurman R, van Vugt M, Rinke de Wit TF on behalf of the PharmAccess African (PASER) and TREAT Asia (TASER) Studies to Evaluate Resistance. Cohort Profile: the PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance – HIV Drug Resistance in sub-Saharan Africa and the Asia-Pacific”. International Journal of Epidemiology, published online 11 November 2010.

Hansudewechakul R, Sirisanthana V, Kurniati N, Puthanakit T, Lumbiganon P, Khairulddin N, Yusoff N, Fong SM, Nallusamy R, Srasuebkul P, Law M, Sohn AH, Chokephailbulkit K for the Asia Pediatric HIV Observational Database. Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia Pediatric HIV Observational Database. JAIDS 2010;55(4):503-9.

Harcourt C, O’Connor J, Egger S, Fairley CK, Wand H, Chen MY, Marshall L, Kaldor JM, Donovan B. The decriminalisation of prostitution is associated with better coverage of health promotion programs for sex workers. Aust NZ J Public Health 2010;34:482-486.

Hoare A, Kerr SJ, Ruxrungtham K, Ananworanich J, Law MG, Cooper DA, Phanuphak P, Wilson DP. Hidden drug resistant HIV to emerge in the era of universal treatment access in Southeast Asia. PloS One 2010;5(6):e10981.

Iversen J, Wand H, Gonnermann A, Maher L. Collaboration of Australian Needle and Syringe Programs. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008. Int J Drug Policy 2010; 21 (6):471-6.

Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, Kippax SC, Kaldor JM, Grulich AE, Wilson DP. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010;24:907-13.

Kariminia A, Chokephaibulkit K, Pang J, Lumbiganon P, Hansudewechakul R, Amin J, Kumarasamy N, Puthanakit T, Kurniati N, Yusoff N, Saphonn V, Fong SM, Razali K, Nallusamy R, Sohn AH, Sirisanthana V. Cohort Profile: The TREAT Asia Pediatric HIV Observational Database. Int J Epidemiol 2010; doi:10.1093/ije/dyp358. PMID: 20100820

Londish G, Templeton DJ, Regan DG, Kaldor JM, Murray JM. Minimal impact of circumcision on HIV acquisition in men who have sex with men. Sex Health 2010;7:463-70.

Lumbiganon P, Kariminia A, Aurpibul L, Hansudewechakul R, Puthanakit T, Kurniati N, Kumarasamy N, Chokephaibulkit K, Nik Khairulddin N, Vonthanak S, Siew Moy F, Azahar Mohd Razali K, Nallusamy R, Sohn A, on behalf of the the TREAT Asia Pediatric HIV Observational Database (TApHOD). Survival of HIV-infected children: A cohort study from the Asia-Pacific region. JAIDS 2010 (Accepted)

Lutgehetmann M, Volz T, Köpke A, Broja T, Tigges E, Lohse AW, Fuchs E, Murray JM, Petersen J, and Dandri M, In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Hepatology 2010. 52(1):16-24.

McNulty AM, Egan C, Wand H, Donovan B. The behaviour and sexual health of young international travellers (backpackers) in Australia. Sex Transm Infect. 2010 Jun;86(3):247-50.

Marashi Pour S, Woolley I, Canavan P, Chuah J, Russell D, Law M, Petoumenos K. Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections. Sexual Health 2010(Accepted)

Martin A, Amin J, Cooper DA, Carr A, Kelleher AD, Bloch M, Baker D, Woolley I, Emery S. Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: A randomized clinical trial. AIDS.2010;24(17):2657-63

Merrall E, Kariminia A, Binswanger I, Hobbs M, Farrell M, Marsden J, Hutchinson S, Bird S. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105:1507-1683

Murray JM, Vallely A, and Page A. When the presumption of innocence is not beneficial: periodic presumptive treatment for STIs and HIV in female sex workers. Sexually Transmitted Infections. 2010 Jun;86(3):161-2.

National Centre in HIV Epidemiology and Clinical Research. Australian HIV Observational Database Annual Report. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney NSW. Volume 10, Number 1: September 2010.

Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J, Sirisanthana T, Chen YM, Pujari S, Kumarasamy N, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; TREAT Asia HIV Observational Database. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med 2010 Sep;11(8):519-29.

Petoumenos K, Worm SW, Reiss P, De Wit S, D’Arminio Monforte A, Sabin C, Friis-Moller N, Weber R, Mercie P, Pradier C, El-Sadr W, Kirk O, Lundgren J, Law M, On behalf of the D:A:D Study Group. Rates of Cardiovascular Disease Following Smoking Cessation in Patients with HIV Infection: Results from the D:A:D Study. HIV Medicine 2010 (Accepted).

Petoumenos K, Hui E, Kumarasamy N, Kerr SJ, Choi JY, Chen YMA, Merati T, Zhang F, Lim PL, Sungkanuparph S, Pujari S, Ponnampalavanar S, Ditangco R, Lee CKC, Grulich A, Law MG for TREAT Asia HIV Obvservational Database. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. Journal of the International AIDS Society 2010;13:51.

Pett SL, Zaunders J, Bailey M, Murray J, MacRae K, Emery S, Cooper DA, and Kelleher AD. A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection. AIDS Research and Human Retroviruses. 2010 Jun;26(6):653-61.

Prasitsuebsai W, Bowen AC, Pang J, Hesp C, Kariminia A, Sohn AH. Pediatric HIV Clinical Care Resources and Management Practices in Asia: A Regional Survey of the TREAT Asia Pediatric Network. AIDS PATIENT CARE and STDs 2010; 24(2):127-31.

Puls RL, Srasuebkul P, Petoumenos K, Boesecke C, Duncombe C, Belloso WH, Molina JM, Li L, Avihingsanon A, Gazzard B, Cooper DA, Emery S; Altair Study Group. Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study. Clin Infect Dis. 2010 Oct 1;51(7):855-64.

Quinn HE, McIntyre PB, Backhouse JL, Gidding HF, Brotherton J, Gilbert GL. The utility of seroepidemiology for tracking trends in pertussi s infection. Epidemiol Infect 2010; 138 (3): 426-433.

Raboud JM, Diong C, Carr A, Grinspoon S, Mulligan K, Sutinen J, Rozenbaun W, Cavalcanti RB, Wand H, Costagliola D, Walmsley S, for the Glitazone and Lipoatrophy Meta-Analysis Working Group. A Meta-Analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy. HIV Clin Trials 2010;11:39-50.

Regan DG, Philp DJ, Waters EK. Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective. Sex Health. 2010;7:368-75.

Ritter A. and Murray JM, Findings regarding reduced prevalence with hepatitis C treatment are still valid: A reply to Vickerman et al. Drug and Alcohol Dependence 2010 (Accepted).

Salmon AM, Van Beek I, Amin J, Kaldor J, Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction.2010;105(4):676-83.

Sandler N, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al and for the INSIGHT SMART Study Group. Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection. The Journal of Infectious Diseases Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2011. 1537-6613/2011/2036-0001$15.00 DOI: 10.1093/infdis/jiq118

Seed CR, Kielt P, Law M, Keller A. No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with men. Transfusion; 2010 Dec;50(12):2722-30.

Seed CR, Kee G, Wong T, Law M, Ismay S. Assessing the safety and efficacy of a test based, targeted screening strategy to minimise transfusion transmitted malaria. Vox Sang 2010;98:e182-e192.

Sungkanuparph S, Oyomopito R, Sirivivhayakul S, Sirisanthana T, Li PCK, Kantipong P, Lee CKC, Kamarulzaman A, Law MG, Phanuphak P on behalf of TASER-M. HIV-1 Drug Resistance Mutations among Antiretroviral-naïve HIV-1-infected Patients in Asia: Results from the TREAT Asia Studies to Evaluate Resistance- Monitoring Study (TASER-M). Clinical Infectious Diseases (accepted).

Vallely A, Page A, Dias S, Siba P, Lupiwa T, Law G, Millan J, Wilson DP, Murray JM, Toole M, Kaldor JM. The prevalence of sexually transmitted infections in Papua New Guinea: A systematic review and meta-analysis. PloS One 2010;5:e15586.

van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM, Grulich AE. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: Population based retrospective cohort study. BMJ.2010;340:c570.

Walter SR, Thein H-H, Amin J, Gidding HF, Ward K, Law MG, George J, Dore GJ. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J Hepatol 2010, DOI: 10.1016/j.jhep.2010.08.035 (Epublished ahead of print).

Wand H, Whitaker C, Ramjee G. Geoadditive models to assess spatial variation of HIV
infections among women in Local communities of Durban, South Africa. International Journal of Health Geographics (in press).

Wand H, Whitaker C, Ramjee G. Assessing and evaluating the risk factors for HIV seroconversion in a cohort of South African women. BMC-Infectious Disease (in press).

Wand H, Ramjee G. Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South Africa. Journal of International AIDS Soc. 2010;13:41.

Wand H, Guy R, Donovan B, McNulty A. Population Attributable Risk for Chlamydia in young international travellers (backpackers) and residents in Australia. British Medical Journal (in press).

Wand H, Guy R, Donovan B, McNulty A. Developing and Validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia: A simple algorithm to identify those at high risk of chlamydia infection. British Medical Journal (in press).

Wand H, Ramjee G. Combined Impact of Sexual Risk Behaviors for HIV Seroconversion Among Women in Durban, South Africa: Implications for Prevention Policy and Planning. AIDS and Behavior. 2010;DOI:10.1007/s10461-010-9845-2.

Wand H, Wilson D, Yan P, McDonald A, Kaldor JM, Law M. Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach. HIV Medicine 2010;11(6):395-403.

Wand H, Carey D, Calmy A, Law M, Cooper D, Emery S, Carr A. Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes. Journal of Clinical Trials 2010;DOI: 10.2147/OAJCT.S14359.

Weber R, Sabin C, Reiss P, de Wit S, Worm SW, Law M, Dabis F, D’Arminio Monforte A, Fontas E, El-Sadr W, Kirk O, Rickenbach M, Phillips, Ledergerber B, Lundgren J for the D:A:D Study Group. HBV or HCV coninfections and risk of myocardial infarction in HIV-infected individuals: The D:A:D Cohort Study. Antiviral Therapy 2010;15: doi: 10.3851/IMP1681

Wilson DP, Regan DG, Heymer K-J, Jin F, Prestage GP, Grulich AE. Serosorting may increase the risk of HIV acquisition among men who have sex with men. Sex Transmitted Dis. 2010;37(1):13-7.

Winston A, Duncombe C, Li PCK, Gill JM, Kerr SJ, Puls R, Petoumenos K, Taylor-Robinson SD, Emery S, Cooper DA, for the Altair Study Group. Choice of combination antiretroviral therapy (cART) alters changes in cerebral function testing after 48 weeks in treatment-naïve, HIV-1 infected subjects commencing cART: a randomised controlled study. Clin Inf Dis 2010 Mar 15;50(6):920-9

Working Group on Estimation of HIV Prevalence in Europe (Wand H a member). HIV in hiding: Methods and data requirements for the estimation of the number of people living with undiagnosed HIV. AIDS 2010 (in Press)

Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D’Arminio Monforte A, Friis-Moller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J for the D:A:D Study Group. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. Journal of Infectious Diseases 2010;201:318-30.

Yan CS, Hanafi I, Kelleher AD, Carr AD, Amin J, McNally LP, Cunningham PH. Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-) viral load at the clinically critical lower limit of quantification. Journal of Clinical Virology. 2010;49(4):249-53.

Zeiler,I, Langlands T, Murray JM, and Ritter A, Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs. Drug and Alcohol Dependence. 2010; 110(3): 228-233.

Zheng H, Ehrlich F, Amin J. Economic evaluation of the direct healthcare cost savings resulting from the use of walking interventions to prevent coronary heart disease in Australia. International Journal of Health Care Finance and Economics.2010;10(2):187-201.

Zheng H, Ehrlich F, Amin J. Productivity loss resulting from coronary heart disease in Australia. Applied Health Economics and Health Policy.2010;8(3):179-89.

Zhou J, Li PC, Kumarasamy N, Boyd M, Chen YM, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang FJ, Omar SF, Lee CK, Ditangco R, Merati TP, Lim PL, Choi JY, Law MG, Pujari S; TREAT Asia HIV Observational Database. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD). HIV Med 2010 Jan;11(1):31-9.

Zhou J, Sirisanthana T, Kiertiburanakul S, Chen YM, Han N, Lim PL, Kumarasamy N, Choi JY, Merati TP, Yunihastuti E, Oka S, Kamarulzaman A, Phanuphak P, Lee CK, Li PC, Pujari S, Saphonn V, Law MG. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infect Dis 2010;10:361.

2009 Publications

Alcantara S, Reece J, Amarasena T, Rose RD, Manitta J, Amin J, Kent SJ. Thrombocytopenia is strongly associated with simian AIDS in pigtail macaques. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):374-9.

Avihingsanon A, van der Lugt J, Kerr SJ, Gorowara M, Chanmano S, Ohata J, Lange J, Cooper DA, Phanuphak P, Burger D, Ruxrungtham K. A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in Thai HIV-1 Infected Adults. Clin Pharm Ther. 2009;85(4):402-408.

Bunupuradah T, Suntarattiwong P, Li A, Sirivichayakul S, Pancharoen C, Boonrak P, Puthanakit T, Kerr SJ, Ruxrungtham K, Chotpitayasunondh T, Hirschel B, Ananworanich J, on behalf of the HIV-NAT 013 study team. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors. Int J Infectious Dis. (In Press)

Byakwaga H, Murray JM, Petoumenos K, Kelleher AD, Law MG, Boyd MA, Emery S, Mallon PW, Cooper DA. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression. AIDS Research and Human Retroviruses. 2009;25(6):756-76.

Byakwaga H, Zhou J, Petoumenos K, Law MG, Boyd MA, Emery S, Cooper DA, Mallon PW. Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy. HIV Med. 2009 Mar;10(3):143-51.

Calmy A, Wand H, Bloch M, Delhumeau C, Finlayson R, Rafferty M, Norris R, Hirschel B, Cooper DA, Carr A ,for the URISTAT study group. No significant effect of uridine or pravastatin for HIV lipoatrophy in men who have ceased thymidine nucleoside analogue therapy: a randomized trial. HIV Medicine (In Press)

Carr A, Amin J. Efficacy and tolerability of initial antiretroviral therapy: a systematic review. AIDS. 2009 Jan 28;23(3):343-53; discussion 355-6. Review.

Chen MY, Millwood IY, Wand H, Poynten M, Law M, Kaldor JM, Wesselingh S, Price CF, Clark LJ, Paull JRA, Fairley CK. A Randomized Controlled Trial of the Safety of Candidate Microbicide SPL7013 Gel When Applied to the Penis. J Acquir Immune Defic Syndr. 2009; 50:375–380.

Dandri M, Petersen J, Murray JM. Reply: Hepatitis B virus clearance rate estimates. Hepatology. 2009;49(5): 1780-1781.

Dore GJ, Hellard M, Matthews G, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, Ffrench R, Rawlinson W, Lloyd AR, and Kaldor JM for the ATAHC Study Group Effective treatment of injecting drug users with recently acquired Hepatitis C virus infection. Gastroenterology 2009 September 23 [Epub ahead of print]

Egger K, Petoumenos K, Kamarulzaman A, Hoy J, Sugkanuparph S, Chuah J, Falster K, Zhou J, Law M, on behalf of the Asia Pacific HIV Observational Database. Long-term patterns in CD4 response is determined by an interaction between baseline CD4 cell count, viral load and time: The Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr. 2009 April; 50(5): 513-520

Falster K, Choi JY, Donovan B, Duncombe C, Mulhall B, Sowden D, Zhou J, Law MG on behalf of the Australian HIV Observational Database, the TREAT Asia HIV Observational Database. AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS 2009;23:2323-2336.

Falster K, Kaldor JM, Maher L. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. J Urban Health 2009, 86: 106-118.

Falster K, Petoumenos K, Chuah J, Mijch A, Mulhall B, Kelly M, Cooper DA, on behalf of the Australian HIV Observational Database. Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression. J Acquir Immune Defic Syndr 2009;50:307-313.

Gidding HF, Topp L, Middleton M, Robinson K, Hellard M, McCaughan G, Maher L, Kaldor JM, Dore GJ, Law MG. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. Journal Gastroenterology and Hepatology 2009;24:1648-1654.

Gidding HF, Wallace C, Lawrence GL, McIntyre PB. Australia's national Q fever vaccination program. Vaccine 2009;27:2037-41.

Grebely J, Matthews G, Petoumenos K and Dore G. Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection. Letter. Journal of Viral Hepatitis 2009 Dec 29. [Epub ahead of print]

Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ and Hellard M for the ATAHC Study Group. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: the ATAHC Study. Drug and Alcohol Dependence 2009 Nov 16. [Epub ahead of print]

Harcourt C, O’Connor J, Egger S, Chen MY, Wand H, Fairley CK, Marshall L, Kaldor JM, Donovan B. Health Promotion for Female Sex Workers in Three Cities with Different Legal Climates. Sexual Health. (In Press)

Haylen BT, Yang V, Logan V, Husselbee S, Law M, Zhou J. Does the presenting bladder volume at urodynamics have any diagnostic relevance? Int Urogynecol J Pelvic Floor Dysfunct. 2009 Mar;20(3):319-24.

Heyward AE, Gidding HF, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009;87:64–71.

Kariminia A, Chokephaibulkit K, Pang J, Lumbiganon p, Hansudewechakul R, Amin J, Kumarasamy N, Puthanakit T, Kurniati T, Khairulddin N, Saphonn V, Fong S, Razali K, Nallusamy R, Sohn A and Sirisanthana V. Cohort Profile: The TREAT Asia Pediatric HIV Observational Database. International Journal of Epidemiology (In Press)

Kerr S, Phanuphak P. As Asian perspective on HIV/AIDS. Asian Biomedicine. 2009;3(1): 9-14.

Kerr SJ, Avihingsanon A, Pucharoen O, Chetchotisakd P, Layton M, Ubolyam S, Ruxrungtham K, Cooper DA, Phanuphak P, Duncombe C. Assessing adherence in Thai patients taking HAART. Int J. STD AIDS. (In Press)

Klug GM, Wand H, Boyd A, Law M, Whyte S, Kaldor J, Masters CL, Collins S. Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster. Brain 2009: 132; 493–501.

Kwon JA, Iverson J, Maher L, Law MG, Wilson DP. The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis. JAIDS 2009;51:462-469.

Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M. TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories. J Virol Methods. 2009 Aug;159(2):185-93.

Martin A, Bloch M, Amin J, Baker D, Cooper DA, Emery S, Carr A. Simplificationof antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial. Clin Infect Dis. 2009 Nov 15;49(10):1591-601.

McDonald A, Zurynski Y, Wand H, Giles M, Elliot E, Kaldor J. Perinatal exposure to HIV among children born in Australia, 1982-2006. Med J Aust. 2009; 190 (8): 416-420.

Mcintyre G, Yu YH, Tran A, Jaramillo A, Arndt A, Millington M, Boyd M, Elliott F, Shen S, Murray J, Applegate T. Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success. Virology Journal. 2009;6(1):184.

McNulty A, Wand H, Egan C, Donovan B. The behaviour and sexual health of young international travellers (backpackers) in Australia. STI-BMJ (In Press)

Merrall E, Kariminia A, Binswanger I, Hobbs M, Farrell M, Marsden J, Hutchinson S, Bird S. Meta-analysis of drug-related deaths soon after release from prison. Addiction (In Press)

Mitsuyasu RT, Merigan TC, Carr A, Zack JA, Winters MA, Workman C, Bloch M, Lalezari J, Becker S, Thornton L, Akil B, Khanlou H, Finlayson R, McFarlane R, Smith DE, Garsia R, Ma D, Law M, Murray JM, von Kalle C, Ely JA, Patino SM, Knop AE, Wong P, Todd AV, Haughton M, Fuery C, Macpherson JL, Symonds GP, Evans LA, Pond SM, Cooper DA. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nature Medicine. 2009;15(3):285-292.

Murray JM, Fanning GC, Macpherson JL, Evans LA, Pond SM, Symonds GP. Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV. The Journal of Gene Medicine. 2009;11(12):1077-1086.

Murray JM, McDonald AM, Law MG. Rapidly ageing HIV epidemic among men who have sex with men in Australia. Sexual Health. 2009;6(1):83-86.

Nakhaee F, Black D, Wand H, McDonald A, Law M. Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003. Sexual Health 2009;6:129-134.

National Centre in HIV Epidemiology and Clinical Research. Australian HIV Observational Database Annual Report. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney NSW. Volume 9, Number 1: November 2009

Nguyen VT, Amin J, Law MG, Dore GJ. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia. J Gastroenterol Hepatol. 2009 Mar;24(3):436-42.

Nguyen VTT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. Journal of Viral Hepatitis 2009;16:453-463.

Prasitsuebsai W, Bowen AC, Pang J, Hesp C, Kariminia A, Sohn AH. Pediatric HIV Clinical Care Resources and Management Practices in Asia: A Regional Survey of the TREAT Asia Pediatric Network. AIDS patient Care STDS (In Press)

Pujari S, Srasuebkul P, Sungkanuparph S, Lim PL, Kumarasamy N, Chuah J, Kumar RN, Chen Y-MA, Oka S, Choi JY, Lee MP, Phanuphak P, Kamarulzaman A, Lee C, Fujie Z, Ditangco R, Saphonn V, Sirisanthana T, Merati TP, Smith J, Law MG. Patient characteristics and treatment outcome associated with Protease Inhibitor (PI) use in the Asia-Pacific region. Antiviral Therapy 2009 doi:10.4172/jaa.1000004.

Puthanaki T, Kerr SJ, Ananworanich J, Bunupuradah T, Boonrak P, Sirisanthana V. Immunological recovery in children starting NNRTI-based highly active antiretroviral therapy in a resource limited setting. Pediatr Infect Dis J 2009;28(6):488-492

Quinn HE, McIntyre PB, Backhouse JL, Gidding HF, Brotherton J, Gilbert GL. The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiol Infect. 2009 Sep 1:1-8. [Epub ahead of print]

Raboud JM, Diong C, Carr A, Grinspoon S, Mulligan K, Sutinen J, Rozenbaun W, Cavalcanti RB, Wand H, Costagliola D, Walmsley S. A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy. HIV Clinical Trials (In Press)

Razali K, Amin J, Dore GJ, Law MG on behalf of the HCV Projections Working Group. Modelling and calibration of the hepatitis C epidemic in Australia. Statistical Methods in Medical Research 2009;18(3):253-270.

Read TRH, Carey D, Mallon P, Mijch A, Goodall R, Hudson F, Wand H, Emery S. Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial. AIDS. 23(16):2222-2223.

Regan DG, Wilson DP, Hocking JS. Authors Reply to Low et al: Use of mathematical modeling to inform chlamydia screening policy. Journal of Infectious Diseases 2009;199:768-769.

Salmon AM, van Beek I, Amin J, Grulich A, Maher L. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre. Aust N Z J Public Health. 2009 Jun;33(3):280-3.

Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism. Current HIV Research (in press)

Seed CR, Kee G, Wong T, Law M, Ismay S. Assessing the safety and efficacy of a test based, targeted screening strategy to minimise transfusion transmitted malaria. E-pub, October 2009 Vox Sanguinis.

Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis. 2009 Apr 1;48(7):940-50.

Srasuebkul P, Sungkanuparph S, Lim PL, Law MG on behalf of the Therapeutics Research Education, and AIDS Training in Asia (TREAT Asia) Observational Database. Reply to DiNubile. Clinical Infectious Diseases 2009;49:811-2.

Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009 Oct;24(10):3225-31.

Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, Chapman JR, Amin J, McDonald SP, Grulich AE. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2297-303.

van der Lugt J, Gorowara M, Avihingsanon A, Burger D, Ananworanich J, Sringam K, Kerr S, Wit F, Lange J, Ruxrungtham K. Reducing the boosting dose of ritonavir does not affect saquinavir levels in HIV-infected individuals. AIDS 2009;23(9):1176-1179

van Leeuwen MT, Grulich AE, McDonald SP, McCredie MR, Amin J, Stewart JH, Webster AC, Chapman JR, Vajdic CM. Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):561-9.

van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood. 2009 Jul 16;114(3):630-7.

Wand H, Spiegelman D, Law MG, Jalaludin B, Kaldor JM, Maher L. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning. Addiction 2009;104:2049-2056.

Wand H, Wilson D, Yan P, Gonnermann A, McDonald A, Kaldor J, Law M. Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method. Journal of International AIDS Society 2009; 12:19 doi:10.1186/1758-2652-12-19.

Wand H, Yan P, Wilson D, McDonald A, Middleton M, Kaldor J, Law M. Characterizing trends in HIV infection among men who have sex with men in Australia by birth-cohorts: results from a modified back-projection method. HIV in Medicine 2010; Doi.1111/j.1468-1293.2009.00804.x.

Wilson DP, Hoare A, Regan DG, Law MG. Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV Epidemic among men who have sex with men. Sexual Health 2009;6:19-33.

Wilson DP, Regan DG, Heymer K-J, Jin F, Prestage GP, Grulich AE. Serosorting may increase the risk of HIV acquisition among men who have sex with men. Sexually Transmitted Diseases 2009;37:13-17.

Winston A, Duncombe C, Li PCK, Gill JM, Kerr SJ, Puls R, Petoumenos K, Taylor-Robinson SJ, Emery S, Cooper DA, for the Altair Study Group. Choice of combination antiretroviral therapy (cART) alters changes in cerebral function testing after 48 weeks in treatment-naïve, HIV-1 infected subjects commencing cART: a randomised controlled study. Clinical Infectious Diseases (In Press)

Wood JG, Gidding HF, Heywood A, Macartney K, McIntyre PB, MacIntyre CR. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine 2009;27:313-318.

Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, D’Arminio Monforte A, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Moller N. Diabetes Mellitus pre-exisiting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with Human Immunodeficiency Virus. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation 2009;119:805-811.

Worm SW, Sabin CA, Reiss P, El-Sadr W, d’Arminio Monforte A, Pradier C, Thiebaut R, Law M, Rickenbach M, de Wit S, Lundgren J, Friss-Moller N. Presence of the Metabolic Syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals. Diabetes Care 2009;32:474-480.

Zheng H, Ehrlich F, Amin J. Economic evaluation of the direct healthcare cost savings resulting from the use of walking interventions to prevent coronary heart disease in Australia. Int J Health Care Finance Econ. 2009 Nov 1.
Zheng H, Orsini N, Amin J, Wolk A, Nguyen VT, Ehrlich F. Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis. Eur J Epidemiol. 2009;24(4):181-92.

Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, Kumarasamy N, Merati TP, Pujari S, Chen YM, Phanuphak P, Vonthanak S, Sirisanthana T, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang F, Tau G, Ditangco R. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis. 2009;9:46.

Zhou J, Li P, Kumarasamy N, Boyd M, Chen Y, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang F, Omar S, Lee C, Ditangco R, Merati T, Lim P, Choi J, Law M, Pujari S. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2009 Jul 6.